Effectiveness of Four Popular Diet Strategies for Weight Loss and Cardiac Risk Reduction

September 13, 2016 updated by: Tufts Medical Center

Effectiveness of Four Dietary Treatment Strategies for Metabolic Syndrome: a Prospective Randomized Trial

A single-center randomized trial at an academic medical center in Boston, Mass, of overweight or obese adults with known hypertension, dyslipidemia, or fasting hyperglycemia. Participants were enrolled starting July 18, 2000, and randomized to 4 popular diet groups until January 24, 2002.

Study Overview

Detailed Description

Objective: To assess adherence rates and the effectiveness of 4 popular diets (Atkins, Zone, Weight Watchers, and Ornish) for weight loss and cardiac risk factor reduction.

Design, Setting, and Participants: A single-center randomized trial at an academic medical center in Boston, Mass, of overweight or obese adults with known hypertension, dyslipidemia, or fasting hyperglycemia. Participants were enrolled starting July 18, 2000, and randomized to 4 popular diet groups until January 24, 2002.

Intervention: A total of 160 participants were randomly assigned to either Atkins (carbohydrate restriction, n=40), Zone (macronutrient balance, n=40), Weight Watchers (calorie restriction, n=40), or Ornish (fat restriction, n=40) diet groups. After 2 months of maximum effort, participants selected their own levels of dietary adherence.

Main Outcome Measures: One-year changes in baseline weight and cardiac risk factors, and self-selected dietary adherence rates per self-report. Outcome measures included body weight, total cholesterol, LDL-C, HDL-C, triglycerides, hsCRP, insulin, glucose.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI 27-42;
  • At least one metabolic cardiac risk factor

Exclusion Criteria:

  • Age under 18 years;
  • Insulin therapy;
  • Unstable chronic illness;
  • Unwilling to follow dietary advice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Atkins Diet
Atkins Diet (dietary counseling)
Dietary counseling for 1 year
Active Comparator: Zone Diet
Zone Diet (dietary counseling)
Dietary counseling for 1 year
Active Comparator: Weight Watchers Diet
Weight Watchers Diet (dietary counseling)
Dietary counseling for 1 year
Active Comparator: Ornish Diet
Ornish Diet (dietary counseling)
Dietary counseling for 1 year

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Loss
Time Frame: 1 year
Change from baseline body weight at 1 year, measured in kilograms
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Cholesterol
Time Frame: 1 year
Change in total cholesterol from baseline at 1 year, measured in mg/dL
1 year
LDL Cholesterol
Time Frame: 1 year
Change from baseline LDL cholesterol at 1 year, measured in mg/dL
1 year
HDL Cholesterol
Time Frame: 1 year
Change from baseline HDL cholesterol at 1 year, measured in mg/dL
1 year
Triglycerides
Time Frame: 1 year
Change from baseline triglycerides at 1 year, measured in mg/dL
1 year
Glucose
Time Frame: 1 year
Change from baseline glucose at 1 year, measured in mg/dL
1 year
Insulin
Time Frame: 1 year
Change from baseline insulin at 1 year, measured in microIU/mL
1 year
C-reactive Protein
Time Frame: 1 year
Change from baseline high-sensitivity CRP at 1 year, measured in mg/L
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael L Dansinger, MD, Tufts Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2000

Primary Completion (Actual)

January 1, 2003

Study Completion (Actual)

January 1, 2004

Study Registration Dates

First Submitted

May 20, 2015

First Submitted That Met QC Criteria

May 26, 2015

First Posted (Estimate)

May 27, 2015

Study Record Updates

Last Update Posted (Estimate)

October 31, 2016

Last Update Submitted That Met QC Criteria

September 13, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Peer-reviewed publication

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Atkins Diet

3
Subscribe